{
  "retracted": false,
  "timestamp": 1437004800000,
  "updates": [
    {
      "timestamp": 1574149210914,
      "identifier": {
        "doi": "10.1182/blood-2015-06-649848"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2015-01-621631"
  },
  "journal": "Blood",
  "publisher": "American Society of Hematology",
  "title": "Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152."
}
